According to the latest report by IMARC Group, the global women’s health diagnostics market reached a value of US$ 21.62 Billion in 2021. It is projected to reach US$ 35.7 Billion by 2027, exhibiting at a CAGR of 8.10% during 2022-2027.
Women’s health diagnostics assists in diagnosing various psychosocial and biological conditions of female patients. It includes advanced laboratory tests, procedures, and tools, such as ultrasound, chemotherapy, biopsy, magnetic resonance imaging (MRI), etc. Women’s health diagnostics aids in addressing pregnancy complications, sexual and vaginal issues, and managing threatening diseases or ailments, including menopause, osteoporosis, breast and cervical cancers, etc. Medical centers offer various laboratory testing solutions to enhance the management of rare diseases and conditions that affect women. As a result, women’s healthcare diagnostics finds widespread applications in hospitals, clinics, nursing homes, home care, etc., across the globe.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Global Women’s Health Diagnostics Market Trends and Drivers:
The escalating prevalence of health issues that impact the overall well-being of women is among the primary factors driving the women’s health diagnostics market. Besides this, the growing awareness towards the benefits of early diagnosis of illnesses is further augmenting the market growth.
Apart from this, the elevating risk of developing certain medical conditions, such as cardiovascular diseases and urinary incontinence, on account of menopause is also catalyzing the global market.
Moreover, the launch of favorable policies by the government bodies to improve the mental health of women is acting as another significant growth-inducing factor. In line with this, the increasing cases of psychiatric disorders, including depression and anxiety, are also stimulating the market growth.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/womens-health-diagnostics-market/requestsample
Furthermore, the rising rate of infertility, owing to the stressful consumer lifestyles and the extensive consumption of alcohol, tobacco, and drugs, is anticipated to bolster the women’s health diagnostics market over the forecasted period.
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Becton Dickinson and Company
Cardinal Health Inc.
Cook Group Incorporated
F. Hoffmann-La Roche AG
General Electric Company
Koninklijke Philips N.V.
Quest Diagnostics Inc.
Siemens AG and Thermo Fisher Scientific Inc.
Global Women’s Health Diagnostics Market Segmentation:
Breakup by Type:
- Diagnostic Devices
- Biopsy Device
- Imaging and Monitoring Devices
- Accessories and Consumables
- Diagnostic Tests
- Breast Cancer Testing
- PAP Smear and HPV Test
- Pregnancy Testing and Ovulation Testing
Breakup by Application:
- Breast Cancer
- Infectious Disease Testing
- Osteoporosis Testing
- Pregnancy and Fertility Testing
- Sexually Transmitted Disease Testing
Breakup by End User:
- Hospital and Diagnostics Centers
- Home Care
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.